6NO9
PIM1 in complex with Cpd16 (5-amino-N-(5-((4R,5R)-4-amino-5-fluoroazepan-1-yl)-1-methyl-1H-pyrazol-4-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide)
Functional Information from GO Data
Functional Information from PDB Data
| site_id | AC1 |
| Number of Residues | 7 |
| Details | binding site for residue GOL A 501 |
| Chain | Residue |
| A | PHE130 |
| A | ILE133 |
| A | THR134 |
| A | ASP170 |
| A | ASP234 |
| A | GLY238 |
| A | HOH639 |
| site_id | AC2 |
| Number of Residues | 7 |
| Details | binding site for residue PO4 A 502 |
| Chain | Residue |
| A | SER261 |
| A | PHE281 |
| A | HOH607 |
| A | HOH611 |
| A | HOH638 |
| A | ARG156 |
| A | ARG258 |
| site_id | AC3 |
| Number of Residues | 4 |
| Details | binding site for residue PO4 A 503 |
| Chain | Residue |
| A | GLU142 |
| A | ARG145 |
| A | HOH603 |
| A | HOH604 |
| site_id | AC4 |
| Number of Residues | 17 |
| Details | binding site for residue KUV A 504 |
| Chain | Residue |
| A | LEU44 |
| A | PHE49 |
| A | ALA65 |
| A | LYS67 |
| A | ILE104 |
| A | LEU120 |
| A | GLU121 |
| A | ARG122 |
| A | VAL126 |
| A | ASP128 |
| A | GLU171 |
| A | ASN172 |
| A | LEU174 |
| A | ILE185 |
| A | ASP186 |
| A | HOH662 |
| A | HOH674 |
Functional Information from PROSITE/UniProt
| site_id | PS00107 |
| Number of Residues | 24 |
| Details | PROTEIN_KINASE_ATP Protein kinases ATP-binding region signature. LGSGGFGSVYsGirvsdnlp..........VAIK |
| Chain | Residue | Details |
| A | LEU44-LYS67 |
| site_id | PS00108 |
| Number of Residues | 13 |
| Details | PROTEIN_KINASE_ST Serine/Threonine protein kinases active-site signature. VlHrDIKdeNILI |
| Chain | Residue | Details |
| A | VAL163-ILE175 |
Functional Information from SwissProt/UniProt
| site_id | SWS_FT_FI1 |
| Number of Residues | 252 |
| Details | Domain: {"description":"Protein kinase","evidences":[{"source":"PROSITE-ProRule","id":"PRU00159","evidenceCode":"ECO:0000255"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI2 |
| Number of Residues | 1 |
| Details | Active site: {"description":"Proton acceptor","evidences":[{"source":"PROSITE-ProRule","id":"PRU00159","evidenceCode":"ECO:0000255"},{"source":"PROSITE-ProRule","id":"PRU10027","evidenceCode":"ECO:0000255"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI3 |
| Number of Residues | 8 |
| Details | Binding site: {"evidences":[{"source":"PROSITE-ProRule","id":"PRU00159","evidenceCode":"ECO:0000255"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI4 |
| Number of Residues | 3 |
| Details | Binding site: {"evidences":[{"source":"PubMed","id":"15525646","evidenceCode":"ECO:0000305"},{"source":"PubMed","id":"15657054","evidenceCode":"ECO:0000305"},{"source":"PubMed","id":"15808862","evidenceCode":"ECO:0000305"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI5 |
| Number of Residues | 2 |
| Details | Modified residue: {"description":"Phosphoserine","evidences":[{"source":"PubMed","id":"15657054","evidenceCode":"ECO:0000269"}]} |
| Chain | Residue | Details |
